NCBI PubMed Central
open access
Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam#1007220
- The Effect of Yoga Training on Menopausal Symptoms on Menopausal Women#1124382
- Effect of cancer epidemiology on treatment efficiency in Kenyan#1082044
- Effectiveness of an Intervention on Vaccine Hesitancy Among Pediatric Nurses and Pediatricians#245563
- MVA Post-Event: Administration Timing and Boost Study#851795
Record · ID 653487
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive